Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Epigenomics
|
July 30, 2019
Downregulation of <i>UBE2T</i> can enhance the radiosensitivity of osteosarcoma <i>in vitro</i> and <i>in vivo</i>
Lin Shen, Kai Zhao, Han Li, et al.
Chemico-Biological Interactions
|
December 25, 2023
Ellagic acid promotes osteoblasts differentiation via activating SMAD2/3 pathway and alleviates bone mass loss in OVX mice
Hui Dong, Yuxia Cao, Ke Zou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 5, 2025
Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi-Omics Analysis
Zheng Li, Jie Guo, Shaopeng Zhu, et al.
Cell Death Discovery
|
October 21, 2025
Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism
Kaiwen Liu, Xiaodi Zhang, Bin Ning, et al.
Experimental Cell Research
|
June 9, 2018
MicroRNA-21a-5p promotes fibrosis in spinal fibroblasts after mechanical trauma
Wenzhao Wang, Shi Tang, Hongfei Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 11, 2026
Naringenin alleviates spinal cord injury by ameliorating macrophage/microglia autophagy via progranulin stabilisation
Chao Wang, Weihang Zhu, Ziran Wei, et al.
Cell Proliferation
|
April 19, 2025
IMPDH2's Central Role in Cellular Growth and Diseases: A Potential Therapeutic Target
Zheng Li, Yunpeng Zou, Jiayao Niu, et al.
Frontiers in Cell and Developmental Biology
|
September 10, 2021
Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling
Kaiwen Liu, Jianlu Wei, Guohua Li, et al.
Frontiers in Oncology
|
October 2, 2025
IQGAP1: cross-disease target via receptor-pathway networks
Shaopeng Zhu, Yunpeng Zou, Jie Guo, et al.
Molecular Medicine Reports
|
February 21, 2025
Research progress of cPLA2 in cardiovascular diseases (Review)
Wenyu Lin, Shuya Wang, Ronghan Liu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Epigenomics
|
July 30, 2019
Downregulation of <i>UBE2T</i> can enhance the radiosensitivity of osteosarcoma <i>in vitro</i> and <i>in vivo</i>
Lin Shen, Kai Zhao, Han Li, et al.
Chemico-Biological Interactions
|
December 25, 2023
Ellagic acid promotes osteoblasts differentiation via activating SMAD2/3 pathway and alleviates bone mass loss in OVX mice
Hui Dong, Yuxia Cao, Ke Zou, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 5, 2025
Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi-Omics Analysis
Zheng Li, Jie Guo, Shaopeng Zhu, et al.
Cell Death Discovery
|
October 21, 2025
Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism
Kaiwen Liu, Xiaodi Zhang, Bin Ning, et al.
Experimental Cell Research
|
June 9, 2018
MicroRNA-21a-5p promotes fibrosis in spinal fibroblasts after mechanical trauma
Wenzhao Wang, Shi Tang, Hongfei Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
January 11, 2026
Naringenin alleviates spinal cord injury by ameliorating macrophage/microglia autophagy via progranulin stabilisation
Chao Wang, Weihang Zhu, Ziran Wei, et al.
Cell Proliferation
|
April 19, 2025
IMPDH2's Central Role in Cellular Growth and Diseases: A Potential Therapeutic Target
Zheng Li, Yunpeng Zou, Jiayao Niu, et al.
Frontiers in Cell and Developmental Biology
|
September 10, 2021
Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling
Kaiwen Liu, Jianlu Wei, Guohua Li, et al.
Frontiers in Oncology
|
October 2, 2025
IQGAP1: cross-disease target via receptor-pathway networks
Shaopeng Zhu, Yunpeng Zou, Jie Guo, et al.
Molecular Medicine Reports
|
February 21, 2025
Research progress of cPLA2 in cardiovascular diseases (Review)
Wenyu Lin, Shuya Wang, Ronghan Liu, et al.
Page
of 4